Novel multimodal analgesic regimen for perioperative pain management after hepatic artery infusion chemotherapy in patients with advanced hepatocellular carcinoma

Table 1 Comparison of general and perioperative data between the two groups, n (%)

Classification	Control group	Multimodal group	t/χ2	P value
Cases	50	50
Age	55.10 ± 8.61	52.00 ± 9.74	1.686	0.095
Gender			0.378	0.539
Male	29 (58)	32 (64)
Female	21 (42)	18 (36)
Child-Pugh class			0.367	0.545
A	27 (54)	30 (60)
B	23 (46)	20 (40)
History of HAIC			0.161	0.688
First time	26 (52)	28 (56)
Twice or more	24 (48)	22 (44)
Adverse life history			0.174	0.677
No	19 (38)	17 (34)
Yes	31 (62)	33 (66)
History of liver disease			0.178	0.673
No	16 (32)	18 (36)
Yes	34 (68)	32 (64)
Complication			0.198	0.656
No	13 (26)	15 (30)
Yes	37 (74)	35 (70)
Duration of HAIC (min)			0.425	0.809
< 30 minutes	32 (64)	35 (70)
30-60 minutes	17 (34)	14 (28)
> 60 minutes	1 (2)	1 (2)
Duration of hospital stay after (day)	3.78 ± 1.87	3.48 ± 1.71	0.839	0.403

HAIC: Hepatic artery infusion chemotherapy.